Skip to Main Content

Paper Details

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer.
Clin Cancer Res
117
2020
Abemaciclib, Anastrozole, Breast Cancer, HER2, HER2- breast cancer, Ki67, PATIENTS, abemaciclib, anastrozole, breast cancer, constipation, diarrhea, early breast cancer, estrogen, gene, nausea, patients, women
Author NameAffiliation
Michael F PressUniversity of Southern California
Philip J Ebert
Dennis J SlamonUniversity of California los angeles
  • 1 - 3

Datasets

Release 1.2